SCWorx Corp. (WORX)
Company Description
SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States.
The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry.
It also offers virtualized item master file repair, expansion and automation; EMR management; CDM management; contract management; request for proposal automation; rebate management; integration of acquired management; big data analytics modeling; data integration and warehousing; and ScanWorx.
In addition, the company operates an online event ticketing platform focused on serving regional mixed martial arts.
In addition, it offers CageTix, a ticketing platform for mixed martial arts industry. Further, the company focuses on selling personal protective equipment and COVID-19 rapid test kits.
It sells its solutions and services to hospitals and health systems through its direct sales force, and distribution and reseller partnerships.
SCWorx Corp. is based in New York, New York.
Country | United States |
Industry | Health Information Services |
Sector | Healthcare |
Employees | 10 |
CEO | Mr. Timothy Andrew Hannibal |
Contact Details
Address:
590 Madison Avenue New York, New York 10022 United States | |
Phone | (212) 739-7825 |
Website | scworx.com |
Stock Details
Ticker Symbol | WORX |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001674227 |
CUSIP Number | 78396V109 |
ISIN Number | US78396V1098 |
Employer ID | 47-5412331 |
SIC Code | 7990 |
Key Executives
Name | Position |
---|---|
Timothy Andrew Hannibal | President, Chief Executive Officer and Director |
Christopher J. Kohler | Chief Financial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 28, 2022 | 8-K | Current Report |
Dec 9, 2022 | 8-K | Current Report |
Nov 14, 2022 | 10-Q | Quarterly Report |
Nov 7, 2022 | DEF 14A | Other definitive proxy statements |
Nov 1, 2022 | PRE 14A | Other preliminary proxy statements |
Oct 25, 2022 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Sep 6, 2022 | 8-K | Current Report |
Aug 15, 2022 | 10-Q | Quarterly Report |
Aug 8, 2022 | 424B3 | Prospectus |
Aug 5, 2022 | EFFECT | Notice of Effectiveness |